CDER Gains Agency-Wide Functions Under Commissioner Office Restructuring
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Drug Evaluation & Research gains several agency-wide functions under the Office of the Commissioner restructuring that took effect June 20.
You may also be interested in...
FDA Deputy Commissioner Friedman To Join Searle
FDA Deputy Commissioner for Operations Michael Friedman, MD, is leaving the agency to join Monsanto's Searle division as senior VP-clinical affairs.
FDA Restructured Legislative Affairs & Policy Office To Be Led By Hubbard
FDA Senior Associate Commissioner William Hubbard will oversee a new office incorporating legislative affairs, policy coordination and planning and evaluation as part of a restructured Office of the Commissioner.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC